FdaApplication
ANDA 213222
Identifiers
- fda_app_no: ANDA213222
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2021-05-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ICATIBANT ACETATE | ICATIBANT ACETATE | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | INJECTABLE;SUBCUTANEOUS |
1 product